Old Web
English
Sign In
Acemap
>
authorDetail
>
K.M. de Winter-de Groot
K.M. de Winter-de Groot
Boston Children's Hospital
Medicine
Pathology
Cystic fibrosis
Intensive care medicine
Ivacaftor
4
Papers
49
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Clinical effect of lumacaftor/ivacaftor in F508del homozygous CF patients with FEV1 ≥ 90% predicted at baseline
2020
Journal of Cystic Fibrosis
B.L. Aalbers
K.M. de Winter-de Groot
H.G.M. Arets
R.W. Hofland
A.C. de Kiviet
M.M.M. van Oirschot-van de Ven
M.A. Kruijswijk
S. Schotman
S. Michel
C.K. van der Ent
Harry G.M. Heijerman
Show All
Source
Cite
Save
Citations (5)
Females with cystic fibrosis have a larger decrease in sweat chloride in response to lumacaftor/ivacaftor compared to males.
2020
Journal of Cystic Fibrosis
B.L. Aalbers
R.W. Hofland
I. Bronsveld
K.M. de Winter-de Groot
H.G.M. Arets
A.C. de Kiviet
M.M.M. van Oirschot-van de Ven
M.A. Kruijswijk
S. Schotman
S. Michel
C.K. van der Ent
Harry G.M. Heijerman
Show All
Source
Cite
Save
Citations (4)
357 Factors associated with changes in health-related quality of life in children with cystic fibrosis during one-year follow-up
2017
Journal of Cystic Fibrosis
M. Van Horck
Bjorn Winkens
Geertjan Wesseling
K.M. de Winter-de Groot
I. de Vreede
Rijn Jobsis
Edward Dompeling
Show All
Source
Cite
Save
Citations (0)
Limited premature termination codon suppression by read-through agents in cystic fibrosis intestinal organoids
2016
Journal of Cystic Fibrosis
D.D. Zomer-van Ommen
L.A.W. Vijftigschild
E. Kruisselbrink
A.M. Vonk
Johanna F. Dekkers
Hettie M. Janssens
K.M. de Winter-de Groot
C.K. van der Ent
Jeffrey M. Beekman
Show All
Source
Cite
Save
Citations (40)
1